Braveheart Bio, Inc. (BRVE) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
4:35 pm
Purchase
2026-09-3013GBRAVEHEART BIO INC
BRVE
Travis Murdoch8,379,470
9.300%
8,379,470increase
(New Position)
Filing
History
2026-11-16
08:00 am
Purchase
2026-09-3013GBRAVEHEART BIO INC
BRVE
Forbion Growth Opportunities Fund III Cooperatief U.A.11,640,546
12.900%
11,640,546increase
(New Position)
Filing
History
2026-11-09
06:02 am
Purchase
2026-09-3013GBRAVEHEART BIO INC
BRVE
Jiangsu Hengrui Pharmaceuticals Co., Ltd.7,420,091
8.200%
7,420,091increase
(New Position)
Filing
History
2026-11-05
1:14 pm
Purchase
2026-09-3013GBRAVEHEART BIO INC
BRVE
FMR LLC7,374,365
8.200%
7,374,365increase
(New Position)
Filing
History
2026-09-10
5:07 pm
Unchanged
2026-09-0813DBRAVEHEART BIO INC
BRVE
ORBIMED ADVISORS LLC12,175,159
13.500%
0
(Unchanged)
Filing
History
2026-08-18
4:59 pm
Purchase
2026-08-0713DBRAVEHEART BIO INC
BRVE
ORBIMED ADVISORS LLC12,175,159
17.200%
12,175,159increase
(New Position)
Filing
History
2026-08-14
4:55 pm
Purchase
2026-08-0713DBRAVEHEART BIO INC
BRVE
AH Bio Fund IV, L.P.10,232,420
11.400%
10,232,420increase
(New Position)
Filing
History
2026-08-14
4:24 pm
Purchase
2026-08-0713GBRAVEHEART BIO INC
BRVE
Frazier Life Sciences Public Fund, L.P.4,976,457
5.500%
4,976,457increase
(New Position)
Filing
History